| dbo:abstract |
1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine (3C-PEP) is a designer drug of the piperazine class of chemical substances. 3C-PEP is related to meta-cholorophenylpiperazine (mCPP) and phenethylamine that can be thought of as mCPP having a phenylethyl group attached to the nitrogen atom at its 4-position. It was first described in 1994 in a patent disclosing a series of piperazine compounds as sigma receptor ligands. Later, it was discovered to be a highly potent dopamine reuptake inhibitor. (en) |
| dbo:casNumber |
136534-45-7 |
| dbo:fdaUniiCode |
3LEH2E7AEU |
| dbo:pubchem |
2845469 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/3C-PEP_structure.png?width=300 |
| dbo:wikiPageID |
47474040 (xsd:integer) |
| dbo:wikiPageLength |
4204 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1107921445 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Designer_drug dbr:D2-like_receptor dbr:United_States dbr:Dopamine_reuptake_inhibitor dbr:Dopamine_transporter dbr:In_vitro dbc:Chlorobenzenes dbc:Dopamine_reuptake_inhibitors dbc:Meta-Chlorophenylpiperazines dbc:Piperazines dbc:Stimulants dbr:Opioid_receptor dbr:Cocaine dbr:Controlled_Drugs_and_Substances_Act dbr:MT-45 dbr:CM156 dbr:Trazodone dbr:5-HT2_receptor dbr:Etoperidone dbr:Affinity_(pharmacology) dbr:Binding_selectivity dbr:Diphenpipenol dbr:Phenethylamine dbr:Piperazine dbr:Meta-Chlorophenylpiperazine dbr:Nefazodone dbr:Serotonin dbr:Serotonin_transporter dbr:Sigma_receptor dbr:Substituted_piperazine dbr:NMDA_receptor dbr:Norepinephrine_transporter dbr:Nitrogen_atom |
| dbp:c |
18 (xsd:integer) |
| dbp:casNumber |
136534 (xsd:integer) |
| dbp:chemspiderid |
2121938 (xsd:integer) |
| dbp:cl |
1 (xsd:integer) |
| dbp:h |
21 (xsd:integer) |
| dbp:iupacName |
1 (xsd:integer) |
| dbp:n |
2 (xsd:integer) |
| dbp:pubchem |
2845469 (xsd:integer) |
| dbp:smiles |
ClC1=CC=CCN2CCNCCC3=CC=CC=C3 (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
NKMGWZZAFWDLFG-UHFFFAOYSA-N (en) |
| dbp:unii |
3 (xsd:integer) |
| dbp:width |
220 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Dopaminergics dbt:Drugbox dbt:More_citations_needed dbt:Reflist dbt:Short_description dbt:Stimulants dbt:Sub dbt:Cascite dbt:Fdacite |
| dct:subject |
dbc:Chlorobenzenes dbc:Dopamine_reuptake_inhibitors dbc:Meta-Chlorophenylpiperazines dbc:Piperazines dbc:Stimulants |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:Drug |
| rdfs:comment |
1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine (3C-PEP) is a designer drug of the piperazine class of chemical substances. 3C-PEP is related to meta-cholorophenylpiperazine (mCPP) and phenethylamine that can be thought of as mCPP having a phenylethyl group attached to the nitrogen atom at its 4-position. It was first described in 1994 in a patent disclosing a series of piperazine compounds as sigma receptor ligands. Later, it was discovered to be a highly potent dopamine reuptake inhibitor. (en) |
| rdfs:label |
1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine (en) |
| owl:sameAs |
yago-res:1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine wikidata:1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine https://global.dbpedia.org/id/zGg2 |
| prov:wasDerivedFrom |
wikipedia-en:1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine?oldid=1107921445&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/3C-PEP_structure.png |
| foaf:isPrimaryTopicOf |
wikipedia-en:1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine |
| is dbo:wikiPageRedirects of |
dbr:1-(3-chlorophenyl)-4-(2-phenylethyl)piperazine dbr:1-(3-chlorophenyl)-4-(2-phenylethyl)piperazine_(3C-PEP) dbr:3C-PEP |
| is dbo:wikiPageWikiLink of |
dbr:1-(3-chlorophenyl)-4-(2-phenylethyl)piperazine dbr:1-(3-chlorophenyl)-4-(2-phenylethyl)piperazine_(3C-PEP) dbr:CM156 dbr:C18H21ClN2 dbr:Substituted_piperazine dbr:3C-PEP |
| is foaf:primaryTopic of |
wikipedia-en:1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine |
